CRONOS GROUP INC. Increase (Decrease) in Accounts Payable
CRONOS GROUP INC. (CRON) reported Increase (Decrease) in Accounts Payable of $3.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- CRONOS GROUP INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $4.32M, a 643.89% increase year-over-year.
- CRONOS GROUP INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$1.21M.
- CRONOS GROUP INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $2.33M, a 41.26% increase year-over-year.
- CRONOS GROUP INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$171.00K.
- CRONOS GROUP INC. increase (decrease) in accounts payable for fiscal 2025 was $1.11M.
- CRONOS GROUP INC. increase (decrease) in accounts payable for fiscal 2024 was -$7.45M.
- CRONOS GROUP INC. increase (decrease) in accounts payable for fiscal 2023 was -$773.00K.
- CRONOS GROUP INC. increase (decrease) in accounts payable for fiscal 2022 was -$863.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $4.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.12M 10-Q · filed 2026-08-06 | $5.45M derived: sum of 3 quarters · filed 2026-08-06 | $5.28M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$1.21M 10-Q · filed 2026-05-11 | $1.13M derived: sum of 2 quarters · filed 2026-05-11 | $958.00K derived: sum of 3 quarters · filed 2026-05-11 | $1.54M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.16M derived: sum of 2 quarters · filed 2026-02-26 | $2.75M derived: sum of 3 quarters · filed 2026-08-06 | $1.11M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$171.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $410.00K derived: sum of 2 quarters · filed 2026-08-06 | -$1.23M 10-Q · filed 2025-11-06 | $426.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $581.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.06M 10-Q · filed 2026-08-06 | $597.00K derived: sum of 3 quarters · filed 2026-08-06 | -$4.02M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$1.64M 10-Q · filed 2026-05-11 | $16.00K derived: sum of 2 quarters · filed 2026-05-11 | -$4.60M derived: sum of 3 quarters · filed 2026-05-11 | -$6.31M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.97M derived: sum of 2 quarters · filed 2026-02-26 | -$4.67M derived: sum of 3 quarters · filed 2026-02-26 | -$7.45M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$4.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$6.33M derived: sum of 2 quarters · filed 2025-11-06 | -$9.10M 10-Q · filed 2025-11-06 | -$2.28M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$4.48M 10-Q · filed 2025-08-07 | $2.34M derived: sum of 3 quarters · filed 2026-02-26 | -$2.78M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$2.77M 10-Q · filed 2025-05-08 | $4.05M derived: sum of 2 quarters · filed 2026-02-26 | -$1.07M derived: sum of 3 quarters · filed 2026-02-26 | -$5.10M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $6.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.71M derived: sum of 2 quarters · filed 2026-02-26 | -$2.33M derived: sum of 3 quarters · filed 2026-02-26 | -$773.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$5.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$9.15M derived: sum of 2 quarters · filed 2024-11-12 | -$7.59M 10-Q · filed 2024-11-12 | -$6.83M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | -$4.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$2.48M 10-Q · filed 2024-08-08 | -$1.71M derived: sum of 3 quarters · filed 2025-02-27 | -$3.82M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $1.55M 10-Q · filed 2024-05-09 | $2.32M derived: sum of 2 quarters · filed 2025-02-27 | $211.00K derived: sum of 3 quarters · filed 2025-02-27 | $870.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $764.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.34M derived: sum of 2 quarters · filed 2025-02-27 | -$685.00K derived: sum of 3 quarters · filed 2025-02-27 | -$863.00K 10-K · filed 2025-02-27 | |
| 2022-09-30 | -$2.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.45M derived: sum of 2 quarters · filed 2023-11-08 | -$1.63M 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $659.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $481.00K 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | -$178.00K 10-Q · filed 2023-05-09 | ||||
| 2021-12-31 | -$1.60M 10-K · filed 2024-02-29 | -$2.37M 10-K · filed 2022-03-01 | |||
| 2021-03-31 | -$3.12M 10-Q · filed 2022-05-10 | ||||
| 2020-12-31 | -$2.78M 10-K · filed 2023-02-28 | -$3.29M 10-K · filed 2022-03-01 | |||
| 2019-12-31 | -$46.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |